Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale
Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy protection in a $256 million deal.
More from Missouri Non-Local Sources
NY Times on Missouri
Caskets on the River: The Story of an American Disaster
Missouri Non-Local Sources
•
1d ago
NY Times on Missouri
Suit Seeks $549 Million for Historically Black College, Citing Disparities
Missouri Non-Local Sources
•
Oct 7, 2026
NY Times on Missouri
Jim Bakker, Television Preacher Felled by Sex and Financial Scandals, Dies at 86
Missouri Non-Local Sources
•
Oct 6, 2026
NY Times on Missouri
Trump Allows Cheaper, Dyed Diesel to Be Used in Nonfarm Vehicles
Missouri Non-Local Sources
•
Oct 6, 2026
NY Times on Missouri
Missouri Man Discovers Michael McDonald of the Doobie Brothers Is His Biological Father
Missouri Non-Local Sources
•
Oct 2, 2026
NY Times on Missouri
Bernadine Bluntly's Brand Was Tradwife. Then She Got Divorced.
Missouri Non-Local Sources
•
Sep 24, 2026
NY Times on Missouri
Private Train Cars Persist In the Era of Private Jets and Luxury Travel
Missouri Non-Local Sources
•
Sep 23, 2026